ArticleFrontiers in genetics2026
A genetic and clinical risk factor algorithm to aid in identifying new cases of chronic kidney disease from the general population.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Scoping Review of Polygenic Risk Scores in Kidney-Related Traits.Kidney international reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The purpose of this study is to develop a genetic test to aid in diagnosing chronic kidney disease (CKD). One challenge in treating CKD is that 80%-90% of people with it are undiagnosed and thus do not access healthcare promptly. The problem arises because early-stage CKD has no overt symptoms, and the current policy is to perform diagnostic tests only when accompanied by risk factors such as old age, hypertension, and diabetes. Methods: This study describes the development of the RICK (RIsk for Chronic Kidney disease) algorithm that employs a polygenic risk score for CKD plus clinical risk factors to identify people at risk. Results: In data from the United Kingdom biobank, those in the top decile of RICK have a ten-fold increased risk of CKD, and approximately 49% of all those with CKD are included in this decile. Furthermore, targeted creatinine testing for those in the highest RICK decile would potentially increase the number of individuals diagnosed with CKD by 7.4%. However, the RICK algorithm adds little value for detecting CKD defined by elevated uACR (albuminuria). Conclusion: Using RICK to selectively test those in the general population with highest risk may help in the early identification of CKD and facilitate early access to renal healthcare. The effectiveness and cost-effectiveness of such testing require further study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.